Allegra CJ - Search Results

1

Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials.

Sinicrope FA, Foster NR, Yoon HH, Smyrk TC, Kim GP, Allegra CJ, Yothers G, Nikcevich DA, Sargent DJ. Sinicrope FA, et al. Among authors: allegra cj. J Clin Oncol. 2012 Feb 1;30(4):406-12. doi: 10.1200/JCO.2011.39.2563. Epub 2011 Dec 27. J Clin Oncol. 2012. PMID: 22203756 Free PMC article. Clinical Trial.

2

5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study.

Loprinzi CL, Ingle JN, Schaid DJ, Buckner JC, Edmonson JH, Allegra CJ. Loprinzi CL, et al. Among authors: allegra cj. Am J Clin Oncol. 1991 Feb;14(1):30-2. doi: 10.1097/00000421-199102000-00006. Am J Clin Oncol. 1991. PMID: 1987734 Clinical Trial.

3

The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.

Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA, Allegra CJ. Johnston PG, et al. Among authors: allegra cj. J Clin Oncol. 1994 Dec;12(12):2640-7. doi: 10.1200/JCO.1994.12.12.2640. J Clin Oncol. 1994. PMID: 7989939 Clinical Trial.

4

Prognostic importance of thymidylate synthase expression in early breast cancer.

Pestalozzi BC, Peterson HF, Gelber RD, Goldhirsch A, Gusterson BA, Trihia H, Lindtner J, Cortés-Funes H, Simmoncini E, Byrne MJ, Golouh R, Rudenstam CM, Castiglione-Gertsch M, Allegra CJ, Johnston PG. Pestalozzi BC, et al. Among authors: allegra cj. J Clin Oncol. 1997 May;15(5):1923-31. doi: 10.1200/JCO.1997.15.5.1923. J Clin Oncol. 1997. PMID: 9164203 Clinical Trial.

5

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.

Allegra CJ, Parr AL, Wold LE, Mahoney MR, Sargent DJ, Johnston P, Klein P, Behan K, O'Connell MJ, Levitt R, Kugler JW, Tria Tirona M, Goldberg RM. Allegra CJ, et al. J Clin Oncol. 2002 Apr 1;20(7):1735-43. doi: 10.1200/JCO.2002.07.080. J Clin Oncol. 2002. PMID: 11919229

6

Issues in clinical trial design for tumor marker studies.

Sargent D, Allegra C. Sargent D, et al. Semin Oncol. 2002 Jun;29(3):222-30. doi: 10.1053/sonc.2002.32898. Semin Oncol. 2002. PMID: 12063675

7

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.

Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N, Wieand HS. Allegra CJ, et al. J Clin Oncol. 2003 Jan 15;21(2):241-50. doi: 10.1200/JCO.2003.05.044. J Clin Oncol. 2003. PMID: 12525515 Clinical Trial.

8

Molecular diagnostics: assays, tissues, progress, and pitfalls.

Allegra C, Sargent D. Allegra C, et al. J Clin Oncol. 2003 Feb 1;21(3):395-6. doi: 10.1200/JCO.2003.11.073. J Clin Oncol. 2003. PMID: 12560423 No abstract available.

9

Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.

Johnston PG, Benson AB 3rd, Catalano P, Rao MS, O'Dwyer PJ, Allegra CJ. Johnston PG, et al. Among authors: allegra cj. J Clin Oncol. 2003 Mar 1;21(5):815-9. doi: 10.1200/JCO.2003.07.039. J Clin Oncol. 2003. PMID: 12610179

10

Microsatellite instability in colon cancer.

Allegra CJ, Kim G, Kirsch IR. Allegra CJ, et al. N Engl J Med. 2003 Oct 30;349(18):1774-6; author reply 1774-6. doi: 10.1056/NEJM200310303491818. N Engl J Med. 2003. PMID: 14585950 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

272 results

Search Page